Ruti Aga's Six-Year Ban: A Knee Injection, a Forged Prescription, and a Marathon Career Shut

A road race in China in March. Ruti Aga won that half marathon. No split from it appears in any report I can find, no finishing time has been published. What survives from that race is not a victory — it is a sample.

The Athletics Integrity Unit's statement came on Thursday. Two years for the presence of a prohibited substance. Four years for tampering. Six in total, dated from 10 September, backdated to the provisional suspension. For a 32-year-old marathoner, six years is not a sanction. It is an end date.

There is almost no performance content in this story, and that is the most honest thing about it. What it does contain is heavier: a knee injury, a family member who became a doctor, and a prescription whose author admitted it was an old pad from a former workplace — belonging to a clinic that did not exist.

The substance was mislabelled in the reporting

A technical correction is unavoidable here, because without it the whole case is misread.

The report calls methylprednisolone a prohibited steroid that WADA classifies as performance-enhancing. That is imprecise. Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9 — not an anabolic steroid, which is S1. And under the current List, glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes.

That single sentence rebuilds the foundation of the case. A knee injection given out-of-competition is lawful. It becomes a violation only if residues are present in a sample taken in-competition. A road race's testing window opens at 23:59 the day before the race, so an injection given four days earlier becomes a question — but the question is about route and timing, not about steroid use.

That was the open defence. Medical records, an injection date, a doctor's registration number, a documented route — with those, a no-significant-fault argument was available. The sanction could have been reduced, or the tampering charge might never have existed. Instead a prescription was manufactured.

Fabrication is only necessary when the real paperwork is missing. That is the heaviest line in this file. And I will repeat an old habit here: I ask the physio first and the coach second, and I write in that order. In this case the physio's chair was empty. That is the actual story.

The arithmetic that opens the panel's mind

The shape of the sanction is standard, not exceptional. Two years for presence — consistent with a Specified Substance finding where intent was not proven. Four years for tampering — the Code's default. Six in total.

Something is buried in that arithmetic. Had the panel accepted a no-significant-fault argument, the presence sanction would have dropped. It did not. And forged documentation is itself circumstantial evidence of concealment intent — yet it did not escalate the presence charge either, it simply became a separate four-year heading. This is a technicality, but it tells you the panel split the evidence into two offences rather than stacking one.

Backdating to 10 September is not a concession. Provisional suspension time counts against the ban; the athlete gains nothing real. On paper it looks like a few months saved. In practice the door had already closed.

Where the knee came from

Intra-articular or peri-articular knee injection is not a hidden practice in distance running. For high-mileage marathoners it is the most common, most available and cheapest tool for lower-limb tendon and joint inflammation. The injection that silences pain on the road becomes a laboratory violation if the timing does not clear.

The real question is not why she took the injection. The real question is where the record of the knee injury is.

An athlete with a credentialed team physician does not forge a prescription. She obtains a Therapeutic Use Exemption, or she respects the route and washout rules and sits the race out. Standing a family member up as a doctor tells you there was no registered medical infrastructure around her. The injury was not being treated. It was being hidden.

The AIU's four-year tampering charge came from an interview, not from a document alone — from statements made under questioning. That is not a small point. Language and translation conditions in AIU interviews with East African athletes have been contested before, and here the panel had the family member's own account: no clinic existed, no medical registration existed, and the clinic disowned the old pad outright. Three independent verification failures.

What the reports left out

No report states that the March race result and its prize money will stand. Standard AIU practice is automatic disqualification of the competition where the sample was collected. Ranking points accrued after that date should be treated as void. This is not written, but assuming the opposite has no basis.

The statement also does not define the retrospective scope. Which means the effect on the 2026 Tokyo Marathon title and three World Marathon Majors runner-up finishes is not settled by this release. Until evidence of earlier use emerges, those results remain on the record. That distinction matters, because sports journalism has a habit of draping a single sanction over an entire career. I will not do that. The scan says clean and the warm-up says otherwise — I keep both, and I say plainly where they disagree.

The marathon that came before

This case cannot be read without Ethiopia's women's marathon depth in view. The top layer runs sub-2:14. The layer beneath it, the title-contention tier, runs sub-2:16. Ruti Aga's range was 2:18 to 2:20 — second in Berlin 2026 in 2:18:34, first in Tokyo 2026 in 2:20:40. That is the major-podium tier, not the title-winning tier.

The consequence: her removal barely moves Ethiopian selection capacity. But it moves her personally, because her income structure sat between the Majors and Asia's road circuit, particularly China's label races. That is the tier where appearance fees are thick and race counts are low. I cannot say how often she raced, but the pattern is plain: selected big-city races, Asian circuit in between. That same circuit is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding on the same roads, in the same races.

India's old yardsticks were different — Railways and Services jobs, leave sanctioned, camp days at Patiala, gaps in a federation calendar. Athletes hid injuries then too, because income rested on a department's paperwork. East Africa's structure is different, with agents and appearance fees and Chinese label races. The logic is identical: when documenting an injury is expensive and hiding it is cheap, the athlete hides it. A glucocorticoid is the most available tool in that system. The forged prescription sits under that governance gap, not under the injury.

Rigour and inconsistency are both true

Six years will be cited two ways. As evidence of AIU rigour — a routine substance, a severe penalty. And as evidence of inconsistent enforcement against African road runners. There is truth in both, which is what unsettles me.

The sanction would not be six years if the prescription had been real. This is a penalty for a document, not for a glucocorticoid. Technically, that is the centre of the case. Emotionally, look at what anabolic steroid cases actually draw. Rarely eight or ten years. Meanwhile a substance with no proven endurance benefit carries six. This is where the letter of the rule and the spirit of the rule part company.

I will not call the sanction right or wrong. I will say that if the standard is document-based, it should read as document-based. The release does not make clear whether the panel treated the tampering as concealment or as evasion of sanction, and the penalty gap between those two readings is wide.

What comes next

Any appeal goes to CAS, with a window that typically runs about 21 days from the reasoned decision. Document-based findings are hard to overturn, and that works against her.

On career terms the age line is blunt. Six years from 32 means a return at 38. In Ethiopia's selection architecture there is no room for a 38-year-old marathoner with a doping record. This is not a six-year ban. It is the rest of a career.

What survives is Tokyo 2026 and Berlin's 2:18:34. Those results remain hers until evidence of earlier use appears.

What does not survive is the question nobody asked: what happened to the knee. Four years from now, when she tries to run again, everyone will ask her about doping and no one will ask about the joint. That is not my complaint. It is the rule of this trade — and the next time a marathoner takes a knee injection four days before a race, she should at least have a real file to show for it.